Signaling pathways involved in the development of cannabinoid tolerance

被引:90
作者
Martin, BR
Sim-Selley, LJ
Selley, DE
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Inst Drug & Alcohol Studies, Richmond, VA 23298 USA
关键词
D O I
10.1016/j.tips.2004.04.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Considerable plasticity exists in the endogenous cannabinoid system, as evidenced by the high degree of tolerance that develops following repetitive exposure to exogenously administered cannabinoid receptor agonists. This tolerance development is accompanied by cannabinoid CB1 receptor downregulation and attenuation of G-protein activation. The biological processes responsible for CB1 receptor downregulation remain to be fully understood. However, recent evidence suggests that several protein kinases participate in the development of cannabinoid tolerance. These observations implicate a role for protein kinases in cannabinoid signaling pathways. It remains to be established whether these protein kinases are directly involved in CB1 receptor regulation or whether they contribute to tolerance by modulating additional signaling pathways.
引用
收藏
页码:325 / 330
页数:6
相关论文
共 58 条
[1]   DEVELOPMENT OF BEHAVIORAL TOLERANCE TO DELTA-9-THC WITHOUT ALTERATION OF CANNABINOID RECEPTOR-BINDING OR MESSENGER-RNA LEVELS IN WHOLE-BRAIN [J].
ABOOD, ME ;
SAUSS, C ;
FAN, F ;
TILTON, CL ;
MARTIN, BR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 46 (03) :575-579
[2]   Time course for the induction and maintenance of tolerance to Δ9-tetrahydrocannabinol in mice [J].
Bass, CE ;
Martin, BR .
DRUG AND ALCOHOL DEPENDENCE, 2000, 60 (02) :113-119
[3]   μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence [J].
Bohn, LM ;
Gainetdinov, RR ;
Lin, FT ;
Lefkowitz, RJ ;
Caron, MG .
NATURE, 2000, 408 (6813) :720-723
[4]   ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASES BY STIMULATION OF THE CENTRAL CANNABINOID RECEPTOR CB1 [J].
BOUABOULA, M ;
POINOTCHAZEL, C ;
BOURRIE, B ;
CANAT, X ;
CALANDRA, B ;
RINALDICARMONA, M ;
LEFUR, G ;
CASELLAS, P .
BIOCHEMICAL JOURNAL, 1995, 312 :637-641
[5]   Chronic Δ9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain [J].
Breivogel, CS ;
Childers, SR ;
Deadwyler, SA ;
Hampson, RE ;
Vogt, LJ ;
Sim-Selley, LJ .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (06) :2447-2459
[6]  
Coutts AA, 2001, J NEUROSCI, V21, P2425
[7]   A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells [J].
Davis, MI ;
Ronesi, J ;
Lovinger, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (49) :48973-48980
[8]   DOWN-REGULATION OF RAT-BRAIN CANNABINOID BINDING-SITES AFTER CHRONIC DELTA-9-TETRAHYDROCANNABINOL TREATMENT [J].
DEFONSECA, FR ;
GORRITI, MA ;
FERNANDEZRUIZ, JJ ;
PALOMO, T ;
RAMOS, JA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 47 (01) :33-40
[9]   The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt [J].
del Pulgar, T ;
Velasco, G ;
Guzmán, M .
BIOCHEMICAL JOURNAL, 2000, 347 :369-373
[10]  
Derkinderen P, 2001, J BIOL CHEM, V276, P38289